Accelerating Antibody Discovery Using BLI Biosensor Technology
Developing and engineering antibodies for diagnostics or therapeutics necessitates comprehensive characterization of an antigen-antibody interaction.
Biolayer Interferometry (BLI) technology has greatly advanced the process of antibody discovery, and the latest platforms offer reliable, high precision analysis which researchers can rely on.
This poster presents data using five different probes, all of which can significantly increase sample throughput, thereby advancing the selection of lead diagnostic and therapeutic antibodies.
Download this poster to discover a technology that can:
- Deliver precise, reliable and reproducible data
- Assess antibody-antigen interactions efficiently
- Enable faster and more cost-effective discovery of antibodies